Agilent invests $80mm in NGS company Lasergen; has option to acquire remainder; option exercised
Drug Discovery Tools
- Drug Discovery Tools
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Research, Analytical Equipment & Supplies
- R+D and Marketing-Licensing
- Includes Equity
- Includes M&A Option
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.